Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
Parkinson's drug study halted early: what we learned
Disease control TerminatedThis study looked at the long-term effects of a drug called UCB0599 (minzasolmin) on brain changes in people with early Parkinson's disease. It involved 428 adults who had already completed a previous study. The goal was to see if starting the drug earlier slowed brain damage com…
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
Newborn seizure drug trial halted early
Symptom relief TerminatedThis study tested a medicine called lacosamide to see if it could reduce seizures in newborns (up to 28 days old) whose seizures were not controlled by standard treatments. The trial was stopped early, so results are limited. It involved 29 babies and compared lacosamide to anoth…
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated May 26, 2026 07:24 UTC
-
New drug UCB3101 put to the test in healthy volunteers
Knowledge-focused TerminatedThis early-stage study tested a single dose of a new drug, UCB3101, in 167 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a placebo, and neither they nor the researchers knew who got which. The …
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC